In order to maintain adequate domestic availability and uptake, the Central Government has imposed a quantitative restriction on syringe export. This is consistent with the government's 'Antyodaya' philosophy, according to which it intends to vaccinate every Indian citizen.
India has administered approximately 94 billion vaccination doses to date, closing in on the 100 billion doses administration record. The ban on syringe exports is due to the fact that they are critical to maintaining the momentum of the covid immunisation programme.
To maintain enough supply for COVID-19 vaccination, the Government of India has imposed a quantitative restriction on the export of 0.5 ml/1ml AD (auto – disable) syringes, 0.5 ml/1 ml/2 ml/3 ml disposable syringes and 1ml/2 ml/3 ml RUP (re-use prevention) syringes.
This quantitative restriction on the export of specific types of specified syringes will be in effect for a three-month period. The administration went on to say that syringes of other denominations are not subject to the same quantitative restrictions and can be exported.
Syringe manufacturers expressed dissatisfaction with the government's decision to restrict syringe exports, claiming that it will tarnish domestic syringe makers' reputation by making them unreliable. They urged the government to lift the restriction on non-COVID sizes of syringes such as insulin syringes, 5ml and large syringe sizes or 0.3 ml AD syringes.